You are here

  • Home
  • Archive
  • Volume 78, Issue 6
  • Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van Mulligen E, de Jong PHP, Kuijper TM, et al
Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study
Annals of the Rheumatic Diseases 2019;78:746-753.